Al-Khazali, Haidar M.
Ashina, Håkan
Wiggers, Astrid
Rose, Kathrine
Iljazi, Afrim
Christensen, Rune Häckert
Schytz, Henrik Winther
Amin, Faisal Mohammad
Ashina, Messoud
Funding for this research was provided by:
Lundbeck Foundation (R310-2018-3711)
Royal Library, Copenhagen University Library
Article History
Received: 23 July 2023
Accepted: 18 August 2023
First Online: 7 September 2023
Declarations
:
: The study protocol was approved by the ethics committee of Capital Region, Denmark, and and written informed consent was obtained from all participants.
: HA reports receiving personal fees from Teva outside of the submitted work. HS reports receiving personal fees from AbbVie, Teva, Lundbeck, Novartis, Eli Lilly, outside of the submitted work. FMA reports receiving personal fees from Pfizer, Teva, Lundbeck, Novartis, and Eli Lilly outside of the submitted work. MA reports receiving personal fees from AbbVie, Amgen, Eli Lilly, GlaxoSmithKline, Lundbeck, Novartis, Pfizer, and Teva Pharmaceuticals outside of the submitted work. MA also serves as an associate editor of Cephalalgia, an associate editor of The Journal of Headache and Pain, and an associate editor of Brain. The remaining authors report no competing interests.